ArticleClinical cancer research : an official journal of the American Association for Cancer Research2018

An Effective Epigenetic-PARP Inhibitor Combination Therapy for Breast and Ovarian Cancers Independent of BRCA Mutations.

Nicholas Pulliam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.